CORRELATIONS BETWEEN INVITRO DISSOLUTION, INVIVO BIOAVAILABILITY AND HYPOGLYCEMIC EFFECT OF ORAL GLIBENCLAMIDE

被引:41
作者
CHALK, JB [1 ]
PATTERSON, M [1 ]
SMITH, MT [1 ]
EADIE, MJ [1 ]
机构
[1] UNIV QUEENSLAND,ROYAL BRISBANE HOSP,DEPT MED,CLIN SCI BLDG,BRISBANE,QLD 4029,AUSTRALIA
关键词
D O I
10.1007/BF00606655
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:177 / 182
页数:6
相关论文
共 4 条
[1]   COMPARISON OF PHARMACOKINETICS OF GLIPIZIDE AND GLIBENCLAMIDE IN MAN [J].
BALANT, L ;
FABRE, J ;
ZAHND, GR .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (01) :63-69
[2]  
CHRIST OE, 1969, HORMONE METABOLIC S, V1, P51
[3]  
FUCRELLA LM, 1973, J CLIN PHARMACOL, V13, P68
[4]   SERUM GLIBENCLAMIDE IN DIABETIC-PATIENTS, AND INFLUENCE OF FOOD ON THE KINETICS AND EFFECTS OF GLIBENCLAMIDE [J].
SARTOR, G ;
MELANDER, A ;
SCHERSTEN, B ;
WAHLINBOLL, E .
DIABETOLOGIA, 1980, 18 (01) :17-22